Session Chair Profile
Ph.D., President and Chief Executive Officer, Toma Biosciences
Wolfgang is an executive and serial entrepreneur in healthcare (diagnostics, medical devices, and health services). Currently he serves as Chairman and CEO of TOMA Biosciences, Inc., a fast growing genomic cancer diagnostic company. Previously Wolfgang was President/CEO of companies Knome (genome interpretation), Castlewood Surgical (heart bypass surgery), Boston Heart Lab (heart diagnostic / Lipidology, and now under Bain one of the fastest growing diagnostic companies in the US), BrainVital (epilepsy), Thermonix (in-stent restenosis), CardioTools (angiography), and Daum (MRI); and relocated with a company acquisition from Germany to the US in 2001. Wolfgang holds a M.S. in Physics from University of Göttingen and a PhD from Technical University Hamburg-Harburg, both Germany. He is a Board member of medical company Precisis and an active angel investor with Launchpad Angels in Boston.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Cancer genomics can improve outcomes and reduce costs. The challenge clinical laboratories face is how to choose from a complex set of unequal partial solutions for biochemistry, bioinformatics and clinical interpretation while meeting the regulatory requirements and providing cost effective services. We propose a simple end-to-end complete solution from tumor to clinical action.